Accumulating evidence points toward a very high prevalence of prolonged neurological
symptoms among coronavirus disease 2019 (COVID-19) survivors. To date, there are no …

More than one year since its emergence, corona virus disease 2019 (COVID-19) is still
looming large with a paucity of treatment options. To add to this burden, a sizeable subset of …

The increasing number of coronavirus disease 2019 (COVID-19) infections have highlighted
the long-term consequences of severe acute respiratory syndrome coronavirus 2 (SARS …

Long COVID or post-COVID-19 syndrome first gained widespread recognition among social
support groups and later in scientific and medical communities. This illness is poorly …

Background A key question concerning coronavirus disease 2019 (COVID‐19) is how
effective and long lasting immunity against this disease is in individuals who were previously …

Background Several studies have reported prolonged symptoms especially neurological
symptoms following acute infection in patients with COVID-19, known as long COVID-19 …

Coronavirus disease 2019 (COVID-19) has caused tremendous morbidity and mortality
worldwide. The large number of post-COVID survivors has drawn attention to the …

Although the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been
widely detected in wastewater in many countries to track the COVID-19 pandemic …

Background The epidemiology of the SARS-CoV-2 B. 1.1. 7 (or Alpha) variant is
insufficiently understood. This study's objective was to describe the introduction and …

Background Assessment of viral kinetics of SARS-CoV-2 can inform on host immune
responses to the virus and on the viral transmission potential. We aimed to characterise viral …